Back to results
US 7,741,491 B2Granted
Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes
AssigneeSanofi-Aventis Deutschland GmbH
InventorsStefan Petry, Karl-Heinz Baringhaus, Norbert Tennangels, Guenter Mueller, Reinhard Kirsch
Life of this patent
Estimating the term…
Abstract
The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.
Claims11
A compound of formula I
- , wherein:
- R1, and R2 are each H;
- R3, R4, and R5 are, independently of one another, selected from H, F, NH—SO2—CH3, COOH, and CO—NH(C1-C6)-alkyl;
- R6 is H;
- A is a bond;
- B is NH;
- and
- D is phenyl;
- or a physiologically tolerated salt thereof.
6 more elements
Dependencies are inferred from the claim text.